The goal of this trial was to assess whether bivalirudin is superior to unfractionated heparin (UFH) in terms of ischemic and hemorrhagic endpoints in troponin-negative patients undergoing ...

A trend towards a lower death rate was shown in the bivalirudin group at 6 months and at 1 year, although MI and revascularization rates tended to be lower in the heparin group at the 6-month stage.

Bivalirudin is a DTI that is FDA approved for anticoagulation in patients with unstable angina who are undergoing percutaneous transluminal coronary angiography; data on the use of bivalirudin in ...

Unfractionated heparin, low-molecular-weight heparin (enoxaparin or fondaparinux) or bivalirudin may be used; unfractionated heparin should be given for 48 hours total and low molecular weight ...